Lewes, DE -- (SBWIRE) -- 06/19/2015 -- Reviewing the domestic vitamin market in May, VE market presented a downturn: oversupply made its price low. Some new entrants have penetrated into VE market, such as Jilin Beisha Pharmaceutical Co.,Ltd. and Fujian Haixin Pharmaceutical Co., Ltd., which will weaken the presence of the current leading enterprises. It's an inevitable trend that the VE price will remain fall in the near future. Due to overcapacity, the price of VB2 kept falling. Under such circumstance, the leader Hubei Guangji Pharmaceutical Co.,Ltd. suffered losses in Q1 2015. VC showed an upward price trend after a continual fall. Stringent environmental protection policy and the upturn of downstream pig farming in future will push up VC price.

As for company dynamic, Nantong Acetic Acid went listed in Shanghai Stock Exchange on 18 May, 2015, which will extend the industrial chain of its 3-cyanopyridine to further develop nicotinamide and nicotinic acid business. Other enterprises like Lonza Group and Vertellus Specialties Inc., launched nicotinamide production in 2014 successively, further intensifying market competition.

According to the data issued by the Ministry of Agriculture of the People's Republic of China in mid-May 2015, the number of live pig in farm was 386.92 million head in April, down by 9.71% YoY and 0.02% MoM. The number of adult sow in farm was 39.71 million head, declining by 14.9% YoY and 1.7% MoM, recording a 20-month consecutive fall. At the same time, the pork's price started to rise. According to the National Development and Reform Commission, the pork's price ended a 14-month decline in April, pig farming turned loss into gain. It's probably that the number of adult sow and live pig in farm will be on the rise, this is beneficial for increasing demand for vitamin from feed industry.

Since Jan. 2015, the domestic market price of VB2 kept falling, under the background of overcapacity and intense competition. In H2, the price is expected to rebound, as the leading enterprises are willing to cut VB2 production to decrease inventory.

Attracted by the increasing supply of 2,3,5-trimethyl hydroquinone in China, more and more new entrants have penetrated into VE industry, lowering the concentration. Further, this made VE oversupply and drove down VE price.

More and more entrants have penetrated into vitamin drink industry, the competition becomes intense.

On 28 April, 2015, PKU Healthcare published its annual report of 2014 and the Q1 2015 financial report. Accordingly, PKU Healthcare disclosed losses in both 2014 and Q1 2015, influenced by the downturn in API market. In the future, the company will make transformation and build a whole industrial chain of healthcare service to get rid of the existing operation predicament.

On 18 May, 2015, Nantong Acetic Acid went listed in Shanghai Stock Exchange. Besides, the company will extend the industrial chain of its 3-cyanopyridine to further develop nicotinamide and nicotinic acid business.

On 28 April, 2015, Northeast Pharmaceutical issued earnings pre-announcement of H1 2015. It's estimated that the company will make losses in H1.

In Q1 2015, both export volume and export value of China's VB12 (derivatives are calculated) had increased sharply, driven by the rising price and increasing demand from overseas market. It's estimated that the export value will be on the rise in a short term.

In Q1 2015, China's export volume of VE had a YoY growth, but its export price underwent a sharp fall.

In Q1 2015, China's export volume of VB6 decreased year on year, mainly due to a sharp fall to Germany.

The domestic market price of nicotinamide started to bounce since April 2015, and it's estimated that its price will keep stable.

Report Covered:

- Market price of VB2 likely to bounce in H2 2015
- Competitive situation in China's VE industry takes on new form
- Intense competition in vitamin drink market
- PKU Healthcare to build whole industrial chain of healthcare service
- Nantong Acetic Acid officially listed in Shanghai Stock Exchange
- Northeast Pharmaceutical predicts losses in H1 2015
- Chinese vitamins Imp. & Exp., March 2015
- China's VB12 exports: YoY growth in value in Q1 2015
- Export price of China's VE keeps falling in Q1 2015
- China's VB6 exports: YoY drop in volume in Q1 2015
- Market prices of vitamins in China, May 2015
- Market price of nicotinamide rebounds since April 2015
- Subsidiaries of Kingdomway obtain production licenses
- Changzhou Niutang suspends VB9 production
- NB Group raises VB2 export price
- Amended Food Safety Law: new requirements for health-care food
- Zhejiang NHU cooperates with DSM
- Yifan Xinfu plans to construct ?-alanine expansion project
- Chongqing Xinfu enjoys preferential corporate income tax

For further information on this report, please visit- http://www.marketresearchreports.com/ccm/vitamin-china-e-news-1505-12-issues-year

Find all Healthcare Report at: http://www.marketresearchreports.com/healthcare

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter